Literature DB >> 304830

Effect of phospholipases on factor-VIII activity.

R Ananthakrishnan, S D'Souza.   

Abstract

The effect of the enzymes phospholipases C and D on Factor VIII were investigated. Phospholipase D was found to activate the partially purified intact Factor-VIII molecule maximally at a final concentration of 0.6 U/ml. Neither the dissociated small molecular weight component nor the high molecular weight component were activated. Phospholipase C, on the other hand, inactivated both the intact and the dissociated Factor-VIII molecule. Phospholipase D, however, had no effect on the haemophilic cryoprecipitate or the partially purified haemophilic Factor VIII. The implications of these results for the genetic control of the Factor-VIII molecule are discussed. In this connection, haemophilia A is hypothesized to be caused by an X-linked enzyme effect that impairs phospholipid assembly of the Factor-VIII protein, whereas von Willebrand's disease might be due to a structural defect of the Factor-VIII protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 304830     DOI: 10.1007/bf00272299

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.

Authors:  H R Gralnick; B S Coller; Y Sultan
Journal:  Science       Date:  1976-04-02       Impact factor: 47.728

2.  Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.

Authors:  M E Switzer; P A McKee
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

Review 3.  Isolation, subunit structure, and proteolytic modification of bovine factor VIII.

Authors:  M E Legaz; M J Weinstein; C M Heldebrant; E W Davie
Journal:  Ann N Y Acad Sci       Date:  1975-01-20       Impact factor: 5.691

4.  Dominant inheritance of hemophilia A in three generations of women.

Authors:  J B Graham; E S Barrow; H R Roberts; W P Webster; P M Blatt; P Buchanan; A I Cederbaum; J P Allain; D A Barrett; H R Gralnick
Journal:  Blood       Date:  1975-08       Impact factor: 22.113

5.  The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors:  R R PROCTOR; S I RAPAPORT
Journal:  Am J Clin Pathol       Date:  1961-09       Impact factor: 2.493

Review 6.  Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand's disease and Christmas disease.

Authors:  E M Barrow; J B Graham
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

7.  Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.

Authors:  H J Weiss; I W Hoyer
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

8.  Isolation and characterization of human Factor VIII (antihemophilic factor).

Authors:  M E Legaz; G Schmer; R B Counts; E W Davie
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

9.  Human factor VIII (antihemophilic factor): activa- tion and inactivation by phospholipases.

Authors:  E J Hershgold; A M Davison; M E Janszen
Journal:  J Lab Clin Med       Date:  1971-02

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.